Crossmark

Loss of heterozygosity related to TMB and TNB may predict PFS for patients with SCLC received the first line setting

Published Online: 2021-09-08

Published Print: 2021-12

Authors

Zhang, Chenyue

Wang, Kai

Wang, Haiyong
Funding

Funding for this research was provided by:

Taishan Scholar Foundation of Shandong Province (tsqn201812149)

Academic promotion program of Shandong First Medical University (2019RC004)
License Information

Text and Data Mining valid from 2021-09-08

Version of Record valid from 2021-09-08
More Information

Article History

Received: 18 May 2021

Accepted: 19 June 2021

First Online: 8 September 2021

Declarations

:

: This study was approved by the ethics committee of Shandong Cancer Hospital and Institute. All included patients in this study offered written informed consent.

: All authors give their consent to publish this manuscript.

: The authors declare that there is no competing interests.

Document is current